Satellos Bioscience (MSLE) Depreciation and Depletion (2025 - 2026)

Satellos Bioscience's (MSLE) quarterly Depreciation and Depletion came in at $1000.0 in Q1 2026, little changed year-on-year from $1000.0 in Q1 2025, and little changed on a QoQ basis from $1000.0 in Q1 2025.

Satellos Bioscience (MSLE) Depreciation and Depletion (2025 - 2026) Analysis & Trends

Satellos Bioscience (MSLE) has 2 years of Depreciation and Depletion data on file, last reported at $1000.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 196,658.72
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 39.39 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.20 Mn
10 Satellos Bioscience 148.71 Mn 148.71 Mn - 1,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 1,000.00
Mar 31, 2026 1,000.00
Mar 31, 2025 1,000.00
Mar 31, 2025 1,000.00